Erratum to “Alloimmunization screening after transfusion of red blood cells in a prospective study” [Rev Bras Hematol Hemoter. 2012;34(3):206–211] (Revista Brasileira de Hematologia e Hemoterapia (2017) 39(2) (186–186), (S1516848417300476) (10.5581/1516-8484.20120051));Alloimmunization screening after transfusion of red blood cells in a prospective study

Revista Brasileira de Hematologia e Hemoterapia

Volumn 34, Issue 3, 2012, Pages 206-211

  Alves, Vitor Mendonça ^a   Martins, Paulo Roberto Juliano ^a   Soares, Sheila ^a   Araújo, Gislene ^b   Schmidt, Luciana Cayres ^c   Costa, Sidneia Sanches de Menezes ^d   Langhi, Dante Mário ^d   Moraes Souza, Helio ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^c Serviço de Pesquisa Fundação Centro de Hematologia E Hemoterapia de Minas Gerais HEMOMINAS   (Brazil)

^d FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Blood group antigens; Emergencies; Hemolysis; Immunophenotyping; Transfusion

Indexed keywords

EID: 84864316477     PISSN: 15168484     EISSN: 18060870     Source Type: Journal    
DOI: 10.1016/j.bjhh.2017.04.001     Document Type: Erratum

References (19)

1. Novaretti MC. Investigação laboratorial em pacientes com anticorpos eritrocitários. In: Bordin JO, Langhi Júnior DM, Covas DT. Hemoterapia: fundamentos e prática. São Paulo: Atheneu; 2007. p 186-89.
2. Baptista-González HA, Rosenfeld-Mann F, Pérez-Pérez JD, Quintanar-Garcia E. Anticuerpos irregulares antieritrocitarios fuera del sistema ABO en el periodo perínatal. Bol Med Hosp Infant Mex. 1991;48(11):814-9.
3. Lee CK, Ma ES, Tang M, Lam CC, Lin CK, Chan LC. Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy-a review of cases from 1997 to 2001. Transfus Med. 2003;13(4):227-31.
4. Serrano J. Incidencia y caracterización de anticuerpos eritrocitários en un banco de sangre hospitalario. Sangre (Barc). 1990;35(5):363-8.
5. Redman M, Regan F, Contreras M. A prospective study of the incidence of red cell alloimmunization following transfusion. Vox Sang. 1996;71(4):216-20.
6. Santos FW, Magalhães SM, Mota RM, Pitombeira MH. Posttransfusion red alloimmunization in patients with acute disorders and medical emergencies. Rev Bras Hematol Hemoter. 2007;29(4):369-72.
7. Schonewille H, Van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion. 2006;46(4):630-5.
8. Thakral B, Saluja K, Sharma RR, Marwaha N. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Hematology. 2008;13(5):313-8.
9. Schonewille H, van de Watering LM, Loomans DS, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006;46(2):250-6.
10. Langhi Júnior DM, Pereira JPM, Pereira CM. Reações transfusionais hemolíticas. In: Bordin JO, Langhi Júnior DM, Covas DT. Hemoterapia: fundamentos e prática. São Paulo: Atheneu; 2007. p. 438-44.
11. Powers A, Chandrashekar S, Mohammed M, Uhl L. Identification and evaluation of false-negative antibody screens. Transfusion. 2010;50(3):617-21.
12. Natukunda B, Schonewille H, Van de Watering L, Brand A. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang. 2010;98(2):167-71.
13. Moore DS. A estatística básica e sua prática. Rio de Janeiro: LTC; 2005.
14. Martins PR, Alves VM, Pereira GA, Moraes-Souza H. [Frequency of irregular antibodies in multiple-transfused patients at the Regional Blood Bank of Uberaba, from 1997 to 2005]. Rev Bras Hematol Hemoter. 2008;30(4):272-6. Portuguese.
15. Cozac AP. Estudo do potencial antigênico relativo dos antígenos de grupos sanguíneos menores em pacientes sob esquema de transfusão [tese]. Ribeirão Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; 2009.
16. Daniels G. Human Blood Groups. 2nd ed. Oxford: Blackwell Science; 2002.
17. Reid ME, Rios M, Powell VI, Charles-Pierre D, Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion. 2000;40(1):48-53.
18. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the RhDnegative blood group phenotype. Blood. 2000;95(1):12-8
19. Schonewille H, Haak HL, Van Zijl AM. RBC antibody persistence. Transfusion. 2000;40(9):1127-31.